Epidemiology And Risk Factors For Death Of Pediatric Burns In A Developing Country. An Experience From The National

N N Lam1,2, N T Hung1, N M Duc1

  • 1National Burn Hospital, Hanoi, Vietnam.

Insights

Pediatric burn patients in Vietnam, primarily preschoolers, often sustained scald injuries. Burn extent and inhalation injury were key predictors of mortality in children.

Area of Science:

  • Pediatric Burn Care
  • Public Health
  • Epidemiology

Background:

  • Pediatric burns represent a significant health concern, particularly in developing nations.
  • Understanding burn characteristics and mortality predictors is crucial for effective intervention.

Purpose of the Study:

  • To investigate burn features in Vietnamese pediatric patients.
  • To identify factors predicting mortality in this population.

Main Methods:

  • Retrospective analysis of pediatric burn patient data.
  • Multivariate logistic regression to determine independent risk factors for death.

Main Results:

  • Pediatric burns constituted 48.1% of admissions; scalds were most common (76.2%).
  • Burn extent and inhalation injury were independent predictors of mortality (OR=1.08 and OR=8.67, respectively).
  • Higher deep burn incidence observed in preschoolers, rural residents, and non-scald burns.

Conclusions:

  • Burn extent and inhalation injury significantly increase mortality risk in pediatric burn patients.
  • Targeted prevention and treatment strategies are needed, especially for vulnerable groups.
  • Findings highlight the need for public health policies addressing pediatric burn injuries in developing countries.

Related Concept Videos

Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...